New pacemaker system aims to improve heart rhythm therapy
NCT ID NCT06620237
First seen Nov 18, 2025 · Last updated Jun 18, 2026 · Updated 30 times
Summary
This study tests the safety and performance of a new pacemaker system (Amvia pacemaker and Solia CSP S lead) for people who need help with their heart's electrical system. The device is designed to pace a specific part of the heart's natural wiring to improve efficiency. 152 participants will be followed for at least a year to monitor for any serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
AZ Sint-Jan
Bruges, 8000, Belgium
-
Auckland City Hospital
Grafton, 1023, New Zealand
-
Catharina Ziekenhuis
Eindhoven, 5623 EJ, Netherlands
-
Centre Hospitalier Metz-Thionville
Metz, 57038, France
-
Clinique Saint-Pierre Ottignies
Ottignies, 1340, Belgium
-
Grand Hôpital de Charleroi
Charleroi, 6060, Belgium
-
Hopital de la Timone (CHU La Timone)
Marseille, 13005, France
-
Hôpital Haut Lévêque (CHU)
Pessac, 33600, France
-
Hôpital privé du Confluent
Nantes, 44277, France
-
Integral Healthcare
Adelaide, 5068, Australia
-
Lyell McEwin Hospital
Elizabeth Vale, 5112, Australia
-
Noordwest Ziekenhuisgroep
Alkmaar, 1815 JD, Netherlands
-
UZ Gent - Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
-
Victorian Heart Hospital
Clayton, 3168, Australia
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.